A new trial explored whether type 2 diabetes patients could get both improved blood sugar control and weight benefits from a single endoscopic procedure called duodenal mucosal resurfacing. Participants either received the procedure or underwent a sham version, letting researchers compare outcomes while minimizing bias. Results could reshape how doctors approach metabolic control in the future.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
